Pneumococcal infection (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Pneumococcal infection" in English language version.

refsWebsite

Global rank English rank

25nih.gov

4^th place

15doi.org

2^nd place

3who.int

195^th place

302^nd place

2cdc.gov

218^th place

212^th place

2semanticscholar.org

11^th place

8^th place

1books.google.com

3^rd place

1harvard.edu

18^th place

17^th place

1bbc.co.uk

8^th place

10^th place

1web.archive.org

1^st place

1nicd.ac.za

low place

bbc.co.uk

news.bbc.co.uk

"Children to be given new vaccine". BBC News. 8 February 2006.

books.google.com

Pratt RD (2022). "5. Pneumococcal Cisease: Infections Caused by Streptococcus pneumoniae". In Jong EC, Stevens DL (eds.). Netter's Infectious Diseases (2nd ed.). Philadelphia: Elsevier. pp. 20–23. ISBN 978-0-323-71159-3.

cdc.gov

"Pneumococcal Vaccination: Information for Health Care Providers". cdc.org. Retrieved 26 July 2016.
"Drug Resistance". cdc.gov. 2019-02-13. Retrieved 17 February 2019.

doi.org

Siemieniuk RA, Gregson DB, Gill MJ (November 2011). "The persisting burden of invasive pneumococcal disease in HIV patients: an observational cohort study". BMC Infectious Diseases. 11 (314): 314. doi:10.1186/1471-2334-11-314. PMC 3226630. PMID 22078162.
Walter ND, Taylor TH, Shay DK, et al. (2010). "Influenza Circulation and the Burden of Invasive Pneumococcal Pneumonia during a Non-pandemic Period in the United States". Clin Infect Dis. 50 (2): 175–183. doi:10.1086/649208. PMID 20014948.
Pericone CD, Overweg K, Hermans PW, Weiser JN (July 2000). "Inhibitory and bactericidal effects of hydrogen peroxide production by Streptococcus pneumoniae on other inhabitants of the upper respiratory tract". Infection and Immunity. 68 (7): 3990–3997. doi:10.1128/IAI.68.7.3990-3997.2000. PMC 101678. PMID 10858213.
Regev-Yochay G, Trzcinski K, Thompson CM, Malley R, Lipsitch M (July 2006). "Interference between Streptococcus pneumoniae and Staphylococcus aureus: In vitro hydrogen peroxide-mediated killing by Streptococcus pneumoniae". Journal of Bacteriology. 188 (13): 4996–5001. doi:10.1128/JB.00317-06. PMC 1482988. PMID 16788209.
Barocchi M, Ries J, Zogaj X, Hemsley C, Albiger B, Kanth A, et al. (2006). "A pneumococcal pilus influences virulence and host inflammatory responses". Proc Natl Acad Sci USA. 103 (8): 2857–2862. Bibcode:2006PNAS..103.2857B. doi:10.1073/pnas.0511017103. PMC 1368962. PMID 16481624.
Li G, Liang Z, Wang X, Yang Y, Shao Z, Li M, et al. (2016). "Addiction of Hypertransformable Pneumococcal Isolates to Natural Transformation for In Vivo Fitness and Virulence". Infect. Immun. 84 (6): 1887–901. doi:10.1128/IAI.00097-16. PMC 4907133. PMID 27068094.
Cui L, Yang R, Huo D, Li L, Qu X, Wang J, et al. (July 2024). "Streptococcus pneumoniae extracellular vesicles aggravate alveolar epithelial barrier disruption via autophagic degradation of OCLN (occludin)". Autophagy. 20 (7): 1577–1596. doi:10.1080/15548627.2024.2330043. PMC 11210924. PMID 38497494.
Werno AM, Murdoch DR (March 2008). "Medical microbiology: laboratory diagnosis of invasive pneumococcal disease". Clin. Infect. Dis. 46 (6): 926–32. doi:10.1086/528798. PMID 18260752.
von Gottberg A, Klugman KP, Cohen C, Wolter N, de Gouveia L, du Plessis M, et al. (March 2008). "Emergence of levofloxacin-non-susceptible Streptococcus pneumoniae and treatment for multidrug-resistant tuberculosis in children in South Africa: a cohort observational surveillance study". Lancet. 371 (9618): 1108–1113. doi:10.1016/S0140-6736(08)60350-5. PMID 18359074. S2CID 205950081.
Peterson LR (January 2006). "Penicillins for treatment of pneumococcal pneumonia: does in vitro resistance really matter?". Clinical Infectious Diseases. 42 (2): 224–233. doi:10.1086/497594. PMID 16355333.
Tleyjeh IM, Tlaygeh HM, Hejal R, Montori VM, Baddour LM (March 2006). "The impact of penicillin resistance on short-term mortality in hospitalized adults with pneumococcal pneumonia: a systematic review and meta-analysis". Clinical Infectious Diseases. 42 (6): 788–797. doi:10.1086/500140. PMID 16477555.
Martínez JA, Horcajada JP, Almela M, Marco F, Soriano A, García E, et al. (February 2003). "Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia". Clinical Infectious Diseases. 36 (4): 389–395. doi:10.1086/367541. PMID 12567294. S2CID 18795735.
Nilsson P, Laurell MH (December 2001). "Carriage of penicillin-resistant Streptococcus pneumoniae by children in day-care centers during an intervention program in Malmo, Sweden". The Pediatric Infectious Disease Journal. 20 (12): 1144–1149. doi:10.1097/00006454-200112000-00010. PMID 11740321.
Block SL, Harrison CJ, Hedrick JA, Tyler RD, Smith RA, Keegan E, et al. (September 1995). "Penicillin-resistant Streptococcus pneumoniae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management". The Pediatric Infectious Disease Journal. 14 (9): 751–759. doi:10.1097/00006454-199509000-00005. PMID 8559623.
Avery OT, Macleod CM, McCarty M (1944). "Studies on the Chemical Nature of the Substance Inducing Transformation of Pneumococcal Types". J. Exp. Med. 79 (2): 137–58. doi:10.1084/jem.79.2.137. PMC 2135445. PMID 19871359.

harvard.edu

ui.adsabs.harvard.edu

Barocchi M, Ries J, Zogaj X, Hemsley C, Albiger B, Kanth A, et al. (2006). "A pneumococcal pilus influences virulence and host inflammatory responses". Proc Natl Acad Sci USA. 103 (8): 2857–2862. Bibcode:2006PNAS..103.2857B. doi:10.1073/pnas.0511017103. PMC 1368962. PMID 16481624.

nicd.ac.za

"Critical decline in pneumococcal disease and antibiotic resistance in South Africa". NICD. Archived from the original on 23 July 2015. Retrieved 20 July 2015.

nih.gov

pubmed.ncbi.nlm.nih.gov

WHO (2007). "Pneumococcal conjugate vaccine for childhood immunization—WHO position paper" (PDF). Wkly Epidemiol Rec. 82 (12). Geneva: World Health Organization: 93–104. PMID 17380597.
Siemieniuk RA, Gregson DB, Gill MJ (November 2011). "The persisting burden of invasive pneumococcal disease in HIV patients: an observational cohort study". BMC Infectious Diseases. 11 (314): 314. doi:10.1186/1471-2334-11-314. PMC 3226630. PMID 22078162.
Walter ND, Taylor TH, Shay DK, et al. (2010). "Influenza Circulation and the Burden of Invasive Pneumococcal Pneumonia during a Non-pandemic Period in the United States". Clin Infect Dis. 50 (2): 175–183. doi:10.1086/649208. PMID 20014948.
Pericone CD, Overweg K, Hermans PW, Weiser JN (July 2000). "Inhibitory and bactericidal effects of hydrogen peroxide production by Streptococcus pneumoniae on other inhabitants of the upper respiratory tract". Infection and Immunity. 68 (7): 3990–3997. doi:10.1128/IAI.68.7.3990-3997.2000. PMC 101678. PMID 10858213.
Regev-Yochay G, Trzcinski K, Thompson CM, Malley R, Lipsitch M (July 2006). "Interference between Streptococcus pneumoniae and Staphylococcus aureus: In vitro hydrogen peroxide-mediated killing by Streptococcus pneumoniae". Journal of Bacteriology. 188 (13): 4996–5001. doi:10.1128/JB.00317-06. PMC 1482988. PMID 16788209.
Barocchi M, Ries J, Zogaj X, Hemsley C, Albiger B, Kanth A, et al. (2006). "A pneumococcal pilus influences virulence and host inflammatory responses". Proc Natl Acad Sci USA. 103 (8): 2857–2862. Bibcode:2006PNAS..103.2857B. doi:10.1073/pnas.0511017103. PMC 1368962. PMID 16481624.
Li G, Liang Z, Wang X, Yang Y, Shao Z, Li M, et al. (2016). "Addiction of Hypertransformable Pneumococcal Isolates to Natural Transformation for In Vivo Fitness and Virulence". Infect. Immun. 84 (6): 1887–901. doi:10.1128/IAI.00097-16. PMC 4907133. PMID 27068094.
Cui L, Yang R, Huo D, Li L, Qu X, Wang J, et al. (July 2024). "Streptococcus pneumoniae extracellular vesicles aggravate alveolar epithelial barrier disruption via autophagic degradation of OCLN (occludin)". Autophagy. 20 (7): 1577–1596. doi:10.1080/15548627.2024.2330043. PMC 11210924. PMID 38497494.
Werno AM, Murdoch DR (March 2008). "Medical microbiology: laboratory diagnosis of invasive pneumococcal disease". Clin. Infect. Dis. 46 (6): 926–32. doi:10.1086/528798. PMID 18260752.
"Pneumococcal vaccines WHO position paper—2012" (PDF). Wkly Epidemiol Rec. 87 (14): 129–44. Apr 6, 2012. PMID 24340399.
von Gottberg A, Klugman KP, Cohen C, Wolter N, de Gouveia L, du Plessis M, et al. (March 2008). "Emergence of levofloxacin-non-susceptible Streptococcus pneumoniae and treatment for multidrug-resistant tuberculosis in children in South Africa: a cohort observational surveillance study". Lancet. 371 (9618): 1108–1113. doi:10.1016/S0140-6736(08)60350-5. PMID 18359074. S2CID 205950081.
Peterson LR (January 2006). "Penicillins for treatment of pneumococcal pneumonia: does in vitro resistance really matter?". Clinical Infectious Diseases. 42 (2): 224–233. doi:10.1086/497594. PMID 16355333.
Tleyjeh IM, Tlaygeh HM, Hejal R, Montori VM, Baddour LM (March 2006). "The impact of penicillin resistance on short-term mortality in hospitalized adults with pneumococcal pneumonia: a systematic review and meta-analysis". Clinical Infectious Diseases. 42 (6): 788–797. doi:10.1086/500140. PMID 16477555.
Martínez JA, Horcajada JP, Almela M, Marco F, Soriano A, García E, et al. (February 2003). "Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia". Clinical Infectious Diseases. 36 (4): 389–395. doi:10.1086/367541. PMID 12567294. S2CID 18795735.
Nilsson P, Laurell MH (December 2001). "Carriage of penicillin-resistant Streptococcus pneumoniae by children in day-care centers during an intervention program in Malmo, Sweden". The Pediatric Infectious Disease Journal. 20 (12): 1144–1149. doi:10.1097/00006454-200112000-00010. PMID 11740321.
Block SL, Harrison CJ, Hedrick JA, Tyler RD, Smith RA, Keegan E, et al. (September 1995). "Penicillin-resistant Streptococcus pneumoniae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management". The Pediatric Infectious Disease Journal. 14 (9): 751–759. doi:10.1097/00006454-199509000-00005. PMID 8559623.
Koiuszko S, Białucha A, Gospodarek E (2007). "[The drug susceptibility of penicillin-resistant Streptococcus pneumoniae]". Medycyna Doswiadczalna I Mikrobiologia. 59 (4): 293–300. PMID 18416121.
Avery OT, Macleod CM, McCarty M (1944). "Studies on the Chemical Nature of the Substance Inducing Transformation of Pneumococcal Types". J. Exp. Med. 79 (2): 137–58. doi:10.1084/jem.79.2.137. PMC 2135445. PMID 19871359.

ncbi.nlm.nih.gov

Siemieniuk RA, Gregson DB, Gill MJ (November 2011). "The persisting burden of invasive pneumococcal disease in HIV patients: an observational cohort study". BMC Infectious Diseases. 11 (314): 314. doi:10.1186/1471-2334-11-314. PMC 3226630. PMID 22078162.
Pericone CD, Overweg K, Hermans PW, Weiser JN (July 2000). "Inhibitory and bactericidal effects of hydrogen peroxide production by Streptococcus pneumoniae on other inhabitants of the upper respiratory tract". Infection and Immunity. 68 (7): 3990–3997. doi:10.1128/IAI.68.7.3990-3997.2000. PMC 101678. PMID 10858213.
Regev-Yochay G, Trzcinski K, Thompson CM, Malley R, Lipsitch M (July 2006). "Interference between Streptococcus pneumoniae and Staphylococcus aureus: In vitro hydrogen peroxide-mediated killing by Streptococcus pneumoniae". Journal of Bacteriology. 188 (13): 4996–5001. doi:10.1128/JB.00317-06. PMC 1482988. PMID 16788209.
Barocchi M, Ries J, Zogaj X, Hemsley C, Albiger B, Kanth A, et al. (2006). "A pneumococcal pilus influences virulence and host inflammatory responses". Proc Natl Acad Sci USA. 103 (8): 2857–2862. Bibcode:2006PNAS..103.2857B. doi:10.1073/pnas.0511017103. PMC 1368962. PMID 16481624.
Li G, Liang Z, Wang X, Yang Y, Shao Z, Li M, et al. (2016). "Addiction of Hypertransformable Pneumococcal Isolates to Natural Transformation for In Vivo Fitness and Virulence". Infect. Immun. 84 (6): 1887–901. doi:10.1128/IAI.00097-16. PMC 4907133. PMID 27068094.
Cui L, Yang R, Huo D, Li L, Qu X, Wang J, et al. (July 2024). "Streptococcus pneumoniae extracellular vesicles aggravate alveolar epithelial barrier disruption via autophagic degradation of OCLN (occludin)". Autophagy. 20 (7): 1577–1596. doi:10.1080/15548627.2024.2330043. PMC 11210924. PMID 38497494.
Avery OT, Macleod CM, McCarty M (1944). "Studies on the Chemical Nature of the Substance Inducing Transformation of Pneumococcal Types". J. Exp. Med. 79 (2): 137–58. doi:10.1084/jem.79.2.137. PMC 2135445. PMID 19871359.

semanticscholar.org

api.semanticscholar.org

von Gottberg A, Klugman KP, Cohen C, Wolter N, de Gouveia L, du Plessis M, et al. (March 2008). "Emergence of levofloxacin-non-susceptible Streptococcus pneumoniae and treatment for multidrug-resistant tuberculosis in children in South Africa: a cohort observational surveillance study". Lancet. 371 (9618): 1108–1113. doi:10.1016/S0140-6736(08)60350-5. PMID 18359074. S2CID 205950081.
Martínez JA, Horcajada JP, Almela M, Marco F, Soriano A, García E, et al. (February 2003). "Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia". Clinical Infectious Diseases. 36 (4): 389–395. doi:10.1086/367541. PMID 12567294. S2CID 18795735.

web.archive.org

"Critical decline in pneumococcal disease and antibiotic resistance in South Africa". NICD. Archived from the original on 23 July 2015. Retrieved 20 July 2015.

who.int

WHO (2007). "Pneumococcal conjugate vaccine for childhood immunization—WHO position paper" (PDF). Wkly Epidemiol Rec. 82 (12). Geneva: World Health Organization: 93–104. PMID 17380597.
"Pneumococcal vaccines WHO position paper—2012" (PDF). Wkly Epidemiol Rec. 87 (14): 129–44. Apr 6, 2012. PMID 24340399.
"WHO bacterial priority pathogens list, 2024: Bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance". www.who.int. Retrieved 2024-12-12.